-
(www.scilifelab.se ). NGI is one of the largest academic providers of next-generation sequencing technology (NGS) and SNP genotyping services in Europe, offering world-class technologies and support to researchers
-
KTH Royal Institute of Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health Job description Professor Tuuli Lappalainen’s research group is looking for a researcher for
-
education at the department occurs in an international environment and is focused on animal biology. Outstanding and high impact research is conducted in a variety of fields, including evolutionary biology
-
will be offered a position in a groundbreaking, international and creative research environment that conducts studies with a basic, translational and clinical focus. Read more on the University website
-
of Science and Technology. Departmental affiliation will be decided in consultations with the successful candidates, based on where their research best fits. Potential host departments include Department
-
strong merit. We are seeking a post-doc candidate who is passionate about answering biological questions related to cancer immunology using cutting edge technology in close collaboration with experimental
-
research environment is characterized by a modern and advanced methodology and has a strong international profile. The institute has 30 research groups with a research staff of 200, of which 60 are PhD
-
, entrepreneurship and leadership training, to develop expertise to address related challenges. Technology and methodology skills: Research methodology and technology training, according to an individually designed
-
is advantageous as well as in CRISPR/Cas9 genetic engineering. Previous work with yeast or another unicellular organism, as well as high throughput screening is also advantageous. Additionally, you
-
at Stockholm University, and collaborate with international members in Spain (Pablo Vargas, Jairo Patiño, Alfredo Reyes), in Canada (Loren Rieseberg), in Norway (Christian Brochmann) and in the UK (Mark Carine